Press release
Masimo Announces Limited Market Release of Sepsis Index
Breakthrough Early Warning Solution, for Integration with Masimo Patient SafetyNet™, Is Designed to Help Clinicians Catch Deterioration in Patient Condition
About this update from Masimo Corporation
[{"type":"text","content":"\nBreakthrough Early Warning Solution, for Integration with Masimo Patient SafetyNet™, Is Designed to Help Clinicians Catch Deterioration in Patient Condition\n\n NEUCHATEL, Switzerland--(BUSINESS WIRE)--\nMasimo (NASDAQ: MASI) today announced the limited market release of Sepsis Index (Si™), an early warning indicator designed to help clinicians identify possible sepsis in patients remotely monitored with Masimo Patient SafetyNet™. Patient SafetyNet, a powerful remote patient monitoring and surveillance system in use around the world, aggregates real-time physiological data from Masimo and third-party bedside monitoring equipment for display at central stations, allowing clinicians to monitor patient condition from afar. By continuously analyzing a variety of vital signs data and other clinical measurements together with EMR data captured by Patient SafetyNet, Si works by quantifying patient status in an easily interpretable sepsis risk score.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221211005045/en/Masimo Patient SafetyNet™ with Sepsis Index (Si™) (Photo: Business Wire)\nSepsis Index, using the aggregated data from Patient SafetyNet, is designed to provide early warning of possible sepsis or other causes of deterioration in a patient’s condition, and to help track patient status following sepsis diagnosis and monitor the effectiveness of treatment and interventions. In addition, Si is designed to display on-screen decision support and recommended actions that each institution can update according to its sepsis policy. The Si algorithm is customizable and draws upon Masimo’s expertise in developing a variety of advanced early warning risk-scoring solutions, such as Halo and Halo ION®, since 2009.\n\nSepsis, a life-threatening condition in which organs malfunction because of widespread infection, is not only common among hospital patients and is a common cause of death.1 The CDC estimates that every year, about 1.7 million adults in the U.S. develop sepsis, of whom at least 350,000 die during their hospitalization or in hospice. One in every three patients who dies in a U.S. hospital had sepsis during their hospitalization.2 Sepsis has also been described as the most expensive condition to treat in the entire U.S. healthcare system, with an estimated $24 billio...